Compare Allstate Corp (ALL) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Allstate Corp vs Novavax Inc — how do they compare? Allstate Corp trades at $262 (market cap $66.31B), while Novavax Inc trades at $7.96 (market cap $1.31B). The key difference: Allstate Corp is far larger — about 50.6× Novavax Inc's market cap, and Allstate Corp pays a 1.65% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| ALL | NVAX | |
|---|---|---|
Market Cap | $66.31B | $1.31B |
Sector | Financials | Health |
52-Week High | $275.11 | $11.19 |
52-Week Low | $190.00 | $6.22 |
Enterprise Value | $74.96B | $889.30M |
Dividend Yield | 1.65% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Allstate Corp
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
